- Home
- WAFU vs SBFM Comparison
WAFU vs SBFM Comparison
Compare WAFU & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- SBFM
- Stock Information
- Founded
- WAFU 1999
- SBFM 2006
- Country
- WAFU China
- SBFM United States
- Employees
- WAFU N/A
- SBFM N/A
- Industry
- WAFU Other Consumer Services
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- SBFM Health Care
- Exchange
- WAFU Nasdaq
- SBFM Nasdaq
- Market Cap
- WAFU 8.8M
- SBFM 3.7M
- IPO Year
- WAFU 2019
- SBFM N/A
- Fundamental
- Price
- WAFU $1.84
- SBFM $3.14
- Analyst Decision
- WAFU
- SBFM
- Analyst Count
- WAFU 0
- SBFM 0
- Target Price
- WAFU N/A
- SBFM N/A
- AVG Volume (30 Days)
- WAFU 59.4K
- SBFM 90.8K
- Earning Date
- WAFU 01-01-0001
- SBFM 11-11-2024
- Dividend Yield
- WAFU N/A
- SBFM N/A
- EPS Growth
- WAFU N/A
- SBFM N/A
- EPS
- WAFU N/A
- SBFM N/A
- Revenue
- WAFU $7,223,220.00
- SBFM $30,481,982.00
- Revenue This Year
- WAFU N/A
- SBFM $86.70
- Revenue Next Year
- WAFU N/A
- SBFM $126.76
- P/E Ratio
- WAFU N/A
- SBFM N/A
- Revenue Growth
- WAFU N/A
- SBFM 109.82
- 52 Week Low
- WAFU $1.58
- SBFM $2.42
- 52 Week High
- WAFU $2.85
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- WAFU 49.50
- SBFM 52.62
- Support Level
- WAFU $1.77
- SBFM $2.85
- Resistance Level
- WAFU $1.91
- SBFM $3.05
- Average True Range (ATR)
- WAFU 0.14
- SBFM 0.14
- MACD
- WAFU -0.02
- SBFM 0.03
- Stochastic Oscillator
- WAFU 17.19
- SBFM 85.29
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.